1.27
前日終値:
$0.97
開ける:
$1.2
24時間の取引高:
20.06M
Relative Volume:
61.68
時価総額:
$7.14M
収益:
$5.64M
当期純損益:
$-23.88M
株価収益率:
-2.3962
EPS:
-0.53
ネットキャッシュフロー:
$-22.36M
1週間 パフォーマンス:
+20.95%
1か月 パフォーマンス:
-7.97%
6か月 パフォーマンス:
-50.78%
1年 パフォーマンス:
-79.25%
Evogene Ltd Stock (EVGN) Company Profile
EVGN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EVGN
Evogene Ltd
|
1.27 | 7.14M | 5.64M | -23.88M | -22.36M | -0.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-10-08 | 開始されました | ROTH Capital | Buy |
2021-07-29 | 開始されました | Aegis Capital | Buy |
2020-12-01 | 開始されました | Cantor Fitzgerald | Overweight |
2013-12-16 | 開始されました | Oppenheimer | Outperform |
Evogene Ltd (EVGN) 最新ニュース
10 Micro-, Small-Cap Companies Lead Monday’s Charge - Insider Monkey
ICL acquires Evogene subsidiary Lavie Bio By Investing.com - Investing.com South Africa
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI - Benzinga
Evogene To Sell Majority Of Lavie Bio To ICL For Undisclosed Terms - Nasdaq
Evogene Announces Sale of Lavie Bio’s Assets to ICL - TipRanks
ICL acquires Evogene subsidiary Lavie Bio - Investing.com
Strategic Acquisition: ICL Takes Over Evogene's Lavie Bio Including Advanced AI Platform for Agriculture - Stock Titan
Evogene (NASDAQ:EVGN) Share Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World
Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com - Defense World
Evogene stock hits 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
Evogene Schedules Third Quarter 2024 Financial Results Release - marketscreener.com
Evogene stock hits 52-week low at $0.99 amid market challenges - Investing.com Australia
Biomica CEO Set to Engage in Panel Discussion at 8th Annual Euro - GuruFocus
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Defense World
Evogene stock hits 52-week low at $1.18 amid market challenges - Investing.com Canada
Evogene stock hits 52-week low at $1.18 amid market challenges By Investing.com - Investing.com South Africa
Evogene (NASDAQ:EVGN) Share Price Passes Below 200 Day Moving Average – What’s Next? - Defense World
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split - Marketscreener.com
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Filing of Annual Report on Form 20-F - GuruFocus.com
AgPlenus Announces Discovery of a New Mode of Action for Fungici - GuruFocus.com
Evogene Ltd. Earnings Call: Growth Amid Challenges - TipRanks
Evogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call Transcript - Insider Monkey
Evogene price target lowered to $6 from $11.25 at Alliance Global Partners - TipRanks
Evogene: Q4 Earnings Snapshot - Barchart
Evogene Ltd to Host Earnings Call - ACCESS Newswire
Evogene Ltd. (NASDAQ:EVGN) Short Interest Up 22.1% in February - Defense World
Evogene Ltd (EVGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - StreetInsider.com
Evogene Ltd. Reports Revenue Growth and Strategic Focus - TipRanks
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve
Earnings call transcript: Evogene Q4 2024 beats EPS forecast, misses revenue - Investing.com
Evogene Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Evogene reports Q4 EPS 6c vs. ($1.30) last year - TipRanks
Evogene reports Q4 revenue miss, shares slip By Investing.com - Investing.com South Africa
Evogene reports Q4 revenue miss, shares slip - Investing.com
Evogene earnings beat by $0.66, revenue fell short of estimates - Investing.com India
SEC Form 424B3 filed by Evogene Ltd - Quantisnow
Evogene (TSE:EVGN) Given New C$3.00 Price Target at Desjardins - Defense World
Evogene Ltd expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Evogene (NASDAQ:EVGN) Now Covered by StockNews.com - Defense World
Evogene Ltd. to Host Earnings Call - ACCESS Newswire
Evogene (EVGN) Projected to Post Quarterly Earnings on Thursday - Defense World
Evogene Schedules Fourth Quarter 2024 Financial Results Release - Krishak Jagat English
Evogene Ltd (EVGN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):